# US 2010/0305326 A1 · Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0305326 A1
- Document ID: US20100305326A1
- Status: Published application
- Kind: A1
- Application number: 12/792,369
- Filed: 2010-06-02
- Published: 2010-12-02
- Earliest claimed: 2009-06-02
- Assignees: Marquette University
- Inventors: Daniel S. Sem
- Web page: https://patentgrep.com/patent/US20100305326A1

## CPC

- C07D 211/68: having one double bond between ring members or between a ring member and a non-ring member
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 25/00: Drugs for disorders of the nervous system
- C07D 215/02: having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D 215/12: with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein are methods related to drug development. The methods typically include steps whereby two chemical fragments are identified as binding to a target protein and subsequently the two chemical fragments are joined to create a new chemical entity that binds to the target protein.

## Claims

### Claim 1

A method for creating a chemical compound, namely A-B, from two chemical fragments, namely A and B, wherein the chemical compound binds to a target protein, the method comprising:
(a) methylating one of the chemical fragments, A, at one or more nucleophilic atoms to obtain a 13CH3-methylated analog of A, namely A-13CH3, by performing an alkylation reaction;
(b) forming a mixture comprising: (1) A-13CH3; (2) the other chemical fragment, B, which comprises an allylic or benzylic methyl group, and (3) the target protein;
(c) determining whether both A-13CH3 and B bind to the target protein in the mixture such that the methyl group of A-13CH3 and the methyl group of B are located no more than 5 angstroms apart; and if so
(d) performing the alkylation reaction of step (a) using A and B as reagents in order to covalently attach A and B via the methyl group carbon atom of B to obtain the chemical compound A-B, optionally wherein the methyl group B first is halogenated and reacts with the nucleophilic atom of A.

### Claim 2 (depends on 1)

The method of claim 1, wherein step (c) comprises performing a nuclear magnetic resonance experiment on the mixture and determining whether a Nuclear Overhauser Effect (NOE) is occurring.

### Claim 3 (depends on 2)

The method of claim 2, wherein determining whether an NOE is occurring comprises performing a 13C-filtered measurement either in a single dimension or in two dimensions.

### Claim 4 (depends on 2)

The method of claim 2, wherein the mixture further comprises a biological sample that comprises the target protein.

### Claim 5 (depends on 4)

The method of claim 4, further comprising performing nuclear magnetic resonance on a mixture formed from: (1) A-13CH3; (2) the other chemical fragment, B, which comprises an allylic or benzylic methyl group, and (3) the biological sample after the target protein has been removed from the biological sample.

### Claim 6 (depends on 4)

The method of claim 4, wherein the biological sample comprises an extract of brain tissue, heart tissue, or liver tissue, which optionally first has been purified on an affinity column that comprises a ligand for the target protein.

### Claim 7 (depends on 1)

The method of claim 1, wherein the target protein is a KCNQ (Kv7) channel protein.

### Claim 8 (depends on 1)

The method of claim 1, wherein the chemical fragment A comprises a nucleophilic atom selected from a nucleophilic carbon, a nucleophilic oxygen, or a nucleophilic sulfur atom and the chemical fragment A is methylated at the nucleophilic atom in step (a) and the chemical fragment A is covalently attached to chemical fragment B via forming a bond between the nucleophilic atom of chemical fragment A and the methyl group carbon atom of chemical fragment B in step (d) after the methyl group carbon atom of chemical fragment B has been halogenated.

### Claim 9 (depends on 1)

The method of claim 1, wherein the chemical fragment A has a formula selected from:

### Claim 10 (depends on 1)

The method of claim 1, wherein the di-methylated chemical fragment A has a formula selected from:

### Claim 11 (depends on 1)

The method of claim 1, wherein the chemical fragment A is a compound selected from the list of compounds in Table 1.

### Claim 12 (depends on 1)

The method of claim 1, wherein the chemical fragment A is obtained by halogenating a compound in Table 2 or Table 3 at an allylic or benzylic methyl group and subsequently reacting the halogenated compound with a thiol anion or an oxy anion.

### Claim 13 (depends on 1)

The method of claim 1, wherein the chemical fragment B is a compound selected from the list of compounds in Table 2 or Table 3.

### Claim 14 (depends on 1)

The method of claim 1, wherein the chemical fragment B includes a fused ring moiety selected from a quinoline, an isoquinoline, and an acridine.

### Claim 15 (depends on 1)

The method of claim 1, wherein the chemical fragment B has a formula selected from:

### Claim 16 (depends on 1)

The method of claim 1, wherein the alkylation reaction comprises:
(i) reacting the chemical fragment A with a strong base and deprotonating the chemical fragment A at a nucleophilic atom selected from carbon, oxygen, or sulfur; and
(ii) reacting the deprotonated chemical fragment A with a methyl halide thereby methylating the chemical fragment A at the nucleophilic atom.

### Claim 17 (depends on 1)

The method of claim 1, wherein the alkylation reaction of step (d) comprises:
(i) reacting the chemical fragment A with a strong base and deprotonating the chemical fragment A at a nucleophilic atom selected from carbon, oxygen, or sulfur;
(ii) halogenating the methyl group of the chemical fragment B to obtain a derivative of chemical fragment B having a halogenated methyl group; and
(iii) reacting the deprotonated chemical fragment A with the derivative of chemical fragment B having the halogenated methyl group, thereby forming a C—C, C—O, or C—S bond between the deprotonated atom of the chemical fragment A and the methyl group carbon of the chemical fragment B.

### Claim 18 (depends on 17)

The method of claim 17, wherein halogenating is performed by reacting the chemical fragment B with N-bromosuccinimide (NBS) or N-chlorosuccinimide (NCS).

### Claim 19

A method for creating a chemical compound, namely A-B, from two chemical fragments, namely A and B, wherein the chemical compound binds to a KCNQ (Kv7) channel protein, the method comprising:
(a) methylating one of the chemical fragments, A, at one or more positions to obtain a 13CH3-methylated analog of A, namely A-13CH3, by performing an alkylation reaction, wherein a di-methylated form of A, namely has a formula selected from:
(b) forming a mixture comprising: (1) the di-methylated form of A; (2) the other chemical fragment, B, which is selected from compounds listed in Table 2 or Table 3, and (3) the KCNQ (Kv7) channel protein;
(c) determining whether both A-13CH3 and B bind to the target protein in the mixture such that the methyl group of A-13CH3 and the methyl group of B are located no more than 5 angstroms apart; and if so
(d) performing the alkylation reaction of step (a) using A and B as reagents in order to covalently attached A and B via the methyl group carbon atom of B to obtain the chemical compound A-B.

### Claim 20 (depends on 19)

The method of claim 19, wherein B is a methyl-substituted pyridine compound.
